US2021127683A1PendingUtilityA1

Methods and compositions of insect control

Assignee: APSE INCPriority: Dec 31, 2015Filed: Oct 20, 2020Published: May 6, 2021
Est. expiryDec 31, 2035(~9.5 yrs left)· nominal 20-yr term from priority
Y02A40/146C12N 15/81C12N 2795/16023A01N 63/60C12N 2770/00042C12N 15/113C12N 2310/14C07K 14/005C12N 15/70C12N 15/1131C12N 2795/18023A01N 63/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A virus-like-particle (VLP) for controlling target insects, the VLP comprising a bacteriophage capsid protein encapsidating an RNA transcript comprising at least one bacteriophage pac sequence coupled to an RNAi precursor sequence targeted against a gene transcript of the insect to suppress expression of the gene in the insect. 
     
     
         2 . The VLP of  claim 1 , wherein the bacteriophage capsid protein derives from a levivirus. 
     
     
         3 . The VLP of  claim 2 , wherein the levivirus is Qβ. 
     
     
         4 . The VLP of  claim 2 , wherein the levivirus is MS2. 
     
     
         5 . The VLP of  claim 1 , wherein the RNAi precursor forms an siRNA. 
     
     
         6 . The VLP of  claim 1 , wherein the RNAi precursor forms an antisense RNA. 
     
     
         7 . The VLP of  claim 1 , wherein the RNA transcript comprises a first bacteriophage pac site, followed by an antisense sequence of the gene, followed by an RNA sequence capable of forming a single-stranded loop, followed by a sense sequence complementary to the antisense sequence of the gene, followed by a second bacteriophage pac site. 
     
     
         8 . The VLP of  claim 1 , wherein the RNA transcript comprises a bacteriophage pac site, followed by an antisense sequence of the gene, optionally followed by one or more bacteriophage pac sites. 
     
     
         9 . The VLP of  claim 1 , wherein the gene is an essential gene. 
     
     
         10 . The VLP of  claim 9 , wherein the essential gene is a gene controlling a larval development event, a gene encoding cellular structural components, or a gene encoding nucleic acid replication, transcription, or translation. 
     
     
         11 . The VLP of  claim 9 , wherein suppression of the essential gene results in death of the insect. 
     
     
         12 . The VLP of  claim 9 , wherein suppression of the essential gene results in the production of sterile off-spring. 
     
     
         13 . The VLP of  claim 9 , wherein the essential gene encodes β-actin. 
     
     
         14 . The VLP of  claim 1 , wherein the target insect is a Lepidopteran insect. 
     
     
         15 . The VLP of  claim 1 , wherein the target insect is a Coleopteran insect. 
     
     
         16 . The VLP of  claim 15 , wherein the Coleopteran insect is bark beetle, elm leaf beetle, Asian longhorn beetle, death watch beetle, mountain pine beetle, coconut hispine beetle, a corn rootworm, or Colorado potato beetle. 
     
     
         17 . The VLP of  claim 1 , wherein the target insect is Colorado potato beetle. 
     
     
         18 . The VLP of  claim 17 , wherein the gene encodes β-actin, and the RNAi precursor sequence is encoded by nucleotides 314-1219 of SEQ ID NO: 6. 
     
     
         19 . The VLP of  claim 17 , wherein the gene encodes β-actin, and the RNAi precursor sequence is encoded by nucleotides 317-820 of SEQ ID NO: 9. 
     
     
         20 . A combination of two or more VLPs of  claim 1 , wherein each RNAi precursor sequence is targeted against a different gene transcript of the insect to suppress expression of each targeted gene in the insect.

Join the waitlist — get patent alerts

Track US2021127683A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.